Improving Access to Healthcare

Improving access to healthcare is an important mission as a pharmaceutical company.

Unmet medical needs and access barriers to essential healthcare caused by social factors such as public health, education and income inequality are social issues regarding health and medical care. We are effectively utilizing internal and external resources to contribute to the resolution of these social issues for improving Access to Healthcare.

Daiichi Sankyo Group Policy on Access to Healthcare

The Daiichi Sankyo Group works to address access to healthcare across its entire value chain, which spans everything from research and development to manufacturing, sales & marketing, and quality & safety management, and prioritizes the following three areas: Research and Development, Availability, and Capacity Building.

Research & Development

Availability

Capacity Building

Through these initiatives, we contribute to the Sustainable Development Goals (SDGs) established by the United Nations, "Goal 3: Ensure healthy lives and promote well-being for all at all ages."

At the same time, we are promoting initiatives for “Goal 9: Industry, Innovation and Infrastructure” and “Goal 17: Partnerships for the Goals.”

sdgsIcon

The Group will contribute to ensuring healthy lives and promoting well-being for all by working to resolve unmet medical needs, such as cancer and other non communicable diseases, rare diseases, malaria, tuberculosis, and neglected tropical diseases.